| 000 | 03458nam a22004335i 4500 | ||
|---|---|---|---|
| 999 |
_c368073 _d368073 _x1 |
||
| 001 | 368073 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121705.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220214s2022 sz | s |||| 0|eng d | ||
| 020 | _a9783030913113 | ||
| 024 | 7 |
_a10.1007/978-3-030-91311-3 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQR188.6 _b2022 EB |
|
| 245 | 1 | 0 |
_aInteraction of Immune and Cancer Cells _cedited by Magdalena Klink, Izabela Szulc-Kielbik. |
| 250 | _aSecond edition 2022 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2022 |
|
| 300 |
_a1 recurso en línea (XIV, 350 páginas) _b22 ilustraciones, 20 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aExperientia Supplementum _x2504-3692 _v113 |
|
| 505 | 0 | _aChapter 1: Cancer immunoediting - elimination, equilibrium and immune escape in solid tumors -- Chapter 2: Tumor - Stroma Interaction and Cancer. - Chapter 3: Tumor-infiltrating lymphocytes and their role in solid tumor progression -- Chapter 4: Tumor-associated macrophages - reasons to be cheerful, reasons to be fearful -- Chapter 5: Polymorphonuclear neutrophils and tumors: friend or foe? -- Chapter 6: Role of NK cells in tumor progression -- Chapter 7: The role of myeloid-derived suppressor cells in tumor growth and metastasis -- Chapter 8: Cancer stem cells - an ever hiding foe -- Chapter 9: Adoptive T-cell immunotherapy - Perfecting self-defenses -- Chapter 10: Monoclonal antibodies to CTLA-4 with focus on ipilimumab. | |
| 520 | _aNow, it its second edition, this book summarizes the role of immune cells in tumor suppression and progression. It describes in detail why tumor cells can survive and spread in spite of the antitumor response of immune cells. Since immunotherapy is an attractive approach to cancer therapy, this book also provides information on the two main strategies: monoclonal antibodies and adaptive T cell immunotherapy, with a focus on recent human clinical trials. A newly added chapter also focuses on the role of Natural Killer cells in tumor progression. The book provides a state-of-the-art, comprehensive overview of immune cells in cancer and is an indispensable resource for researchers and practitioners working or lecturing in the field of cancer research and immunology. | ||
| 988 | _aSpringer_BiomedLife_2022 | ||
| 650 | 7 |
_2embne _9348509 _aCáncer _xInmunoterapia |
|
| 700 | 1 |
_aKlink, Magdalena _eeditor literario _0(orcid)0000-0002-9870-7391 _1https://orcid.org/0000-0002-9870-7391 _4edt _4http://id.loc.gov/vocabulary/relators/edt _948636 |
|
| 700 |
_aSzulc-Kielbik, Izabela _eeditor literario _0(orcid)0000-0003-1290-697X _1https://orcid.org/0000-0003-1290-697X _4edt _4http://id.loc.gov/vocabulary/relators/edt _9683530 |
||
| 776 | 0 | 8 |
_iPrinted edition: _z9783030913106 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030913120 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030913137 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-91311-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE _n0 |
||
| 998 |
_b04/2022 _dz _ep _zSI |
||